Jay Truitt is a Dermatology pharmacist affiliated with Texas Tech University. OpenAlex indexes 17 publications with 515 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6102 82nd St Ste 15
Lubbock, TX 794240840
Telephone
806-749-7933Provider last certified this registry record 13 Aug 2025.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20254 payments
- Ortho Dermatologics, a division of Bausch Health US, LLCProgram year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
36.4%Corticosteroid36.4%Clobetasol Propionate56%Hydrocortisone44%Part D<11 patientsAnti-infectives
27.2%Azole Antifungal16%Ketoconazole100%Part D≥12 patientsTetracycline-class Drug11.1%Doxycycline Monohydrate100%Part D<11 patientsDermatology
20.4%Corticosteroid20.4%Triamcinolone Acetonide100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Histologic changes of basal cell carcinomas during vismodegib treatment
Baylor University Medical Center Proceedings
2024 - Guanfacine treatment for a patient with delusional parasitosis causing dermatillomania presenting with shared psychiatric disorders
Baylor University Medical Center Proceedings
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Javier Corral, MD
Texas Tech University
Marc Zuckerman, MD
Texas Tech University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”